A Phase II Study to Assess the Ability of Neoadjuvant Chemotherapy +/- Second Look Surgery to Eliminate All Measurable Disease Prior to Radiotherapy for NGGCT
ACNS0232
A Phase III Group-Wide Study
STUDY CHAIR: Jeffrey C. Allen, M.D.
פרוטוקולים
TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED MEDULLOBLASTOMA, SUPRATENTORIAL PRIMITIVE NEUROECTODERMAL TUMOR, OR ATYPICAL TERA TOID RHABDOID TUMOR – SJMB03
16:47
אין תגובות
Amendment 2.0, September 8, 2005, Resubmitted May 31, 2006
A Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy
9:45
אין תגובות
ARET0332
A Groupwide Phase III Study
STUDY CHAIR: Murali Chintagumpala, M.D.
Trial of Systemic Neoadjuvant Chemotherapy for Group B Intraocular Retinoblastoma
9:42
אין תגובות
ARET0331
A Phase III Limited Institution Study
STUDY CHAIR: Debra L. Friedman
SIOPEL4 – Intensified pre-operative chemotherapy and radical surgery for HIGH RISK HEPATOBLASTOMA
17:22
אין תגובות
Final Version July 2004
A PILOT STUDY OF INTENSIVE CHEMOTHERAPY WITH PERIPHERAL STEM CELL SUPPORT FOR INFANTS WITH MALIGNANT BRAIN TUMORS
17:07
אין תגובות
CCG-99703
A Phase I/II Groupwide Study
STUDY CHAIR: Bruce Cohen, M.D
